Market Growth and Consumer Interest Trends Industry analysis reveals that the reduced glutathione for injection market has maintained steady growth from 2019 through 2024, with particularly robust expansion projected from 2025 to 2033
Nigam, S., Ciccoli, R., Ivanov, I., Sczepanski, M
Int 2021 , 7880448 (2021)
As of August 2026, Eli Lilly has not yet submitted the Biologics License Application for retatrutide, though all four core TRIUMPH Phase 3 trials are now complete
"Promomed vyvodit na rynok pervyi otechestvennyi liraglutid" [Promomed launches the first domestic liraglutide]
Three Convenient Sizes 3mL Perfect for single peptide vials or small-scale studies 10mL Ideal for multiple reconstitutions or larger research protocols 30mL Best value for high-volume research use Product Specifications Composition: Deionized Pure Water + 0.9% Benzyl Alcohol (USP) Sterile & Filtered Ready for immediate use Multi-Use Vial Bacteriostatic formulation allows multiple withdrawals USP Grade Meets United States Pharmacopeia standards Clear & Particle-Free Visual inspection verified Sealed & Tamper-Evident Quality assurance from manufacturing to delivery Why Researchers Choose Our Reconstitution Solution Unlike standard sterile water, our bacteriostatic formulation remains stable after opening, reducing waste and ensuring consistent reconstitution across your research timeline